Medita Clinic in Tartu
Sexual health Advisory Center
Tartu mnt 16
entrance by Rävala pst
Gynaecology, Urology, Vascular surgery , Genergal surgery, Neurosurgery and Orthopaedy
Registration desk 17101
The registration desk is open
Genetic risk test for colorectal cancer (AnteCRC)Who can benefit from AnteCRC:
- Men and women between the ages of 40-75 of European origin (Note: Genetic risk studies used by AnteCRC have been conducted in populations of European descent).
- analyzes of 91 genetic variants associated with colorectal cancer;
- individual polygenic risk score for colorectal cancer;
- the individual risk of colorectal cancer compared to the rest of the population;
- likelihood to get colorectal cancer in 10 years and risk assessment compared to a person with average genetic risk;
- interpretation of the test results with clinical recommendations.
AnteCRC test is not used to diagnose colorectal cancer;
AnteCRC test is not validated for use by individuals of non-European descent;
An elevated risk estimated by the AnteCRC test does not mean that you will develop colorectal cancer during your lifetime. Also, a moderate or lower risk does not mean that the probability of developing the diseases is zero;
AnteCRC test does not assess the risk of your family and relatives, i.e. polygenic risk score-based disease risks may not be transmitted directly from parents to children;
AnteCRC test does not analyze rare pathogenic mutations in genes that significantly increase the risk of colorectal cancer, such as APC, KRAS, TP53, MLH1, MSH2, MSH6, PMS2, STK11, MUTYH and others;
AnteCRC test is based on the most up-to-date scientific data, which may, however, be supplemented and changed in the future as additional information becomes available. The field of genetics is constantly evolving, which may lead to changes in risk assessments over time, as well as changes in test selection recommendations and clinical recommendations based on test results;
Different polygenic risk scores predicting risks of the same trait may give different estimates of the individual’s risks due to differences in the genetic variants included in the models and their weights;
The results of this test should be applied in context with other relevant clinical data. In addition to the possible genetic predisposition, other risk factors also influence the risk of colorectal cancer.
Testing is offered in collaboration with the Antegenes laboratory.